Novo Nordisk Sees Financial Giants Take Bullish Stance, Benzinga Reports

Deep-pocketed investors have adopted a bullish approach towards $Novo-Nordisk A/S(NVO.US)$, Benzinga reported, citing 21 extraordinary options activities for the stock. About 71% of the trades were leaning bullish and 19% bearish, according to the report. Four of these were puts, totaling $206,445, and 17 were calls, amounting to $1,195,302, it said.

Trading activity data signals that the investors were targeting a price range of $97.5 to $150 for Novo Nordisk over the recent three months. The stock traded at $126.69, down 0.1% at 3:16 p.m. in New York Monday. Read the full report here: Options Corner: Novo Nordisk Sees Financial Giants Take Bullish Stance